Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Headache. 2016 Mar 26;56(4):741–749. doi: 10.1111/head.12793

Association of migraine headaches with suicidal ideation among pregnant women in Lima, Peru

Lauren E Friedman (1), Bizu Gelaye (1), Marta B Rondon (2), Sixto E Sánchez (3),(4), B Lee Peterlin (5), Michelle A Williams (1)
PMCID: PMC4837000  NIHMSID: NIHMS760357  PMID: 27016264

Abstract

Background

Suicide is a leading cause of maternal death globally, and suicide prevalence rates have been shown to be increased in those with migraine. No previous study has examined the association between migraine and suicidal ideation during pregnancy.

Objective

To examine the association between migraine and suicidal ideation among a cohort of pregnant women.

Methods

A cross-sectional study was conducted among 3,372 pregnant women attending prenatal care clinics in Lima, Peru. Suicidal ideation and depression were assessed using the Patient Health Questionnaire-9 (PHQ-9) scale during early pregnancy. Migraine classification (including migraine and probable migraine) was based on International Classification of Headache Disorders (ICHD)-III beta criteria. Multivariable logistic regression analyses were performed to estimate odd ratios (OR) and 95% confidence intervals (95%CI).

Results

Suicidal ideation was more common among those with migraine (25.6%) as compared to those with probable migraine (22.1%, p<0.001) or non-migraineurs (12.3%, p<0.001). After adjusting for confounders, including depression, those with migraine or probable migraine had a 78% increased odds of suicidal ideation (OR=1.78; 95%CI: 1.46–2.17), as compared with non-migraineurs. Women with both migraine and depression had a 4.14-fold increased odds of suicidal ideation (OR=4.14; 95%CI: 3.17–5.42) compared to those with neither condition.

Conclusion

Migraine is associated with increased odds of suicidal ideation in pregnant women even when controlling for depression. These findings support the consideration of screening women with comorbid migraine and depression for suicidal behavior during pregnancy.

Keywords: Migraine, Depression, Suicidal Ideation, Pregnancy

Introduction

Migraine headaches are an often debilitating neurologic disorder with an estimated worldwide prevalence of 10–15% 1, 2. Migraine is most common among adults 18 to 49 years old 3, 4 as compared to those at either ends of the age distribution, and among women as compared to men 5, 6. Additionally migraine has been shown to be comorbid with several psychiatric disorders including depression and suicide 79. Suicide is currently a leading cause of maternal death in developed countries 10, 11 and in low and middle income countries 12, 13. Estimated rates of suicide vary widely between countries 14. Suicidal behaviors, including suicidal ideation, having a suicide plan, and unsuccessful suicide attempts, are the strongest predictors of suicide. While suicidal ideation is often a defining symptom of depressive disorders, suicidal ideation may occur without accompanying depression 15, 16. Notably, recent studies have demonstrated that a substantial proportion of pregnant women with suicidal ideation do not meet clinical thresholds for depressive disorders 17, 18.

There is limited evidence concerning the association of migraine with suicidal ideation in pregnancy 19. Therefore, we sought to examine the extent to which migraine is associated with suicidal ideation among a cohort of pregnant women in Peru. Furthermore, we sought to explore the independent and joint effects of migraine and depression on the odds of suicidal ideation.

Methods

Study Population

The study population was a cohort of 3,372 participants from a larger ongoing cohort of the Pregnancy Outcomes, Maternal and Infant Study (PrOMIS). The PrOMIS cohort was designed to examine maternal social and behavioral risk factors of preterm birth and adverse pregnancy outcomes among Peruvian women 2023. The study population includes women attending prenatal care clinics enrolled in the Instituto Nacional Materno Perinatal (INMP) in Lima, Peru. The INMP is the primary reference establishment for both maternal and perinatal care operated by the Ministry of Health of the Peruvian government. Recruitment began in February 2012. Pregnant women were eligible for inclusion if they were between the ages of 18 and 49 years, with a gestational age 16 weeks, and who spoke and understood Spanish. All participants provided written informed consent, and all study procedures were approved by Institutional Review Boards from the INMP, Lima, Peru and the Human Research Administration Office at the Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

Analytical Population

The study population for this report is derived from information collected from participants who enrolled in the PrOMIS Study between February 2012 and March 2014. During this period 3,775 eligible women were approached, and 3,372 (89.3%) agreed to participate. Forty three (1.2%) women were excluded for missing information on the suicide ideation question on the PHQ-9 questionnaire (thoughts that you would be better off dead or of hurting yourself in some way). Of the 43 participants with missing information on the suicidal ideation question, 35 participants had missing information on other items of the PHQ-9. Twenty-two women were excluded for missing information on their migraine history. A total of 3,323 pregnant women remained for analysis. The excluded participants did not differ from the rest of the cohort in regards to sociodemographic or lifestyle characteristics.

Migraine Assessment

Migraine was classified by trained interviewers using a Spanish-language questionnaire, administered during early pregnancy, and based on the International Classification of Headache Disorders (ICHD)-III beta criteria 24. Probable migraine was classified as those fulfilling all but one of the migraine diagnostic criteria.

Suicidal Ideation and Depression Assessment

Depression and suicidal ideation were assessed using a Spanish-language version of the Patient Health Questionnaire-9 (PHQ-9) 25, 26. The PHQ-9 is a nine item depression screening tool that has been validated in this population 17, 27. The questionnaire assesses 9 depressive symptoms on the 14 days prior to evaluation. The PHQ-9 score is calculated by assigning a score of 0–3 to the response categories “not at all” “several days” “more than half the days” and “nearly every day”. Suicidal ideation was assessed based on the PHQ-9 question inquiring as to patients having “thoughts that you would be better off dead or of hurting yourself in some way”. Participants who responded to this question with “several days” “more than half the days” and “nearly every day” were categorized as affirmative for suicidal ideation. The question asking about suicidal ideation was not considered in the total score for depression. The first 8 questions (PHQ-8) were used to calculate a depression score. Participants were categorized as ‘yes’ for depression with a PHQ-8 score 10, similar to the cutoff for the PHQ-9. The use of the PHQ-8 depression questionnaire has been demonstrated to minimally influence overall scale performance, mean scores or diagnostic cut points as compared with use of PHQ-9 28, 29.

Other Covariates

All subjects participated in structured interviews that included a questionnaire with information about sociodemographic, headache characteristics, and depression. Participants were also interviewed regarding sociodemographic characteristics. Participants’ age was categorized as: 18–19, 20–29, 30–34, and 35 years old. Other covariates include education ( 6, 7–12, >12 years of education); pre-pregnancy self-reported body mass index (BMI) and early pregnancy measured BMI (<18.5, 18.5–24.9, 25–29.9, >30); ethnicity (Mestizo vs. others); marital status (married/living with partner vs. others); employment status (employed vs. not employed); difficulty paying for the very basics (hard vs. not very hard); difficulty paying for medical care (hard vs. not very hard); parity (nulliparous vs. multiparous); planned pregnancy (yes vs. no); and gestational age at interview.

Statistical Analysis

Participants’ demographic and reproductive characteristics were first examined. Continuous variables were presented as mean ± standard deviations (SD). Categorical variables were expressed as number (percent, %). Chi-square tests were used to evaluate differences in the distribution of categorical variables. Student's t-tests were used to evaluate differences in means. Multivariable logistic regression procedures were used to estimate odds ratios (OR) and 95% confidence intervals (95%CI) for suicidal ideation in relation to migraine diagnosis. Covariates were entered into each model individually, and adjusted and unadjusted ORs were compared to assess confounding. The final adjusted models included variables that were previously identified as potential confounders or altered the adjusted OR by at least 10%. Given that depression has been implicated as an important comorbid disorder with migraine, we repeated the analyses stratified by maternal depression status. We also explored the independent and joint effects of migraine and depression on the odds of suicidal ideation by categorizing participants into four groups based on the combination of depression and migraine status. The four categories examined were: (1) no migraine and no depression, (2) depression only, (3) migraine only, and (4) both migraine and depression. Pregnant women with no migraine and no depression were considered as the reference group and compared with women in the other three categories. All reported p-values are two sided with a statistical significance set at 0.05. Statistical analyses were performed using SPSS (IBM SPSS v22.0, Chicago, IL).

Results

The sociodemographic and reproductive characteristics of the study population are presented in Table 1. The average age of study participants was 28.2 years (SD=6.3); and the average gestational age at the interview was 9.2 weeks (SD=3.5). The majority of participants were Mestizos of mixed European and Amerindian descent (75.4%), married or living with a partner (81%), and multiparous (51.1%). Overall, compared to women without migraine, migraineurs were more likely to be unemployed, have difficulty paying for the basics and for medical care, have multiparous pregnancies, and do not identify as Mestizo (Table 1).

Table 1.

Characteristics of the study population according to migraine status (N = 3,323)

Characteristics All participants (N = 3,323)
No migraine (N = 2,200)
Probable migraine (N = 716)
Migraine (N = 407)
P-value
n % n % n % n %
Age (years) a 28.19 ± 6.30 28.35 ± 6.29 27.82 ± 6.34 27.92 ± 6.28 0.099
Age (years)
 18–19 172 5.2 114 5.2 38 5.3 20 4.9 0.43
 20–29 1848 55.6 1196 54.4 417 58.2 235 57.7
 30–34 700 21.1 477 21.7 135 18.9 88 21.6
 ≥35 603 18.1 413 18.8 126 17.6 64 15.7
Education (years)
 ≤6 145 4.4 92 4.2 32 4.5 21 5.2 0.135
 7–12 1806 54.5 1180 53.7 416 58.3 210 51.9
 >12 1363 41.1 924 42.1 265 37.2 174 43.0
Pre-pregnancy self-reported BMI
 <18.5 kg/m2 33 1.2 19 1.0 11 1.8 3 0.9 0.488
 18.5–24.9 1471 53.1 985 54.2 307 50.9 179 51.1
 25–29.9 962 34.7 613 33.7 220 36.5 129 36.9
 >30 305 11.0 201 11.1 65 10.8 39 11.1
Early pregnancy measured BMI
 <18.5 kg/m2 63 1.9 30 1.4 27 3.8 6 1.5 0.001
 18.5–24.9 1582 48.2 1053 48.5 322 45.5 207 51.4
 25–29.9 1210 36.9 792 36.5 277 39.1 141 35.0
 >30 428 13.0 297 13.7 82 11.6 49 12.2
Mestizo ethnicity 2501 75.4 1650 75.1 576 80.4 275 67.7 <0.001
Married/living with a partner 2679 81.0 1764 80.6 584 81.9 331 81.5 0.705
Employed 1525 45.9 1069 48.6 286 39.9 170 41.8 <0.001
Difficulty paying for basics
 Hard 1649 49.7 1016 46.2 397 55.4 236 58.0 <0.001
 Not very hard 1672 50.3 1182 53.8 319 44.6 171 42.0
Difficulty paying for medical care
 Hard 1760 53.1 1067 48.7 438 61.2 255 62.8 <0.001
 Not very hard 1554 46.9 1125 51.3 278 38.8 151 37.2
Nulliparous 1621 48.9 1103 50.3 340 47.6 178 43.8 0.040
Planned pregnancy 1390 42.1 948 43.3 291 40.9 151 37.4 0.063
Gestational age at interview a 9.24 ± 3.46 9.25 ± 3.47 9.27 ± 3.41 9.18 ± 3.45 0.903
Thoughts that you would be better off dead or of hurting yourself in some way
 No 2790 84.0 1929 87.7 558 77.9 303 74.4 <0.001
 Yes 533 16.0 271 12.3 158 22.1 104 25.6
Depression (PHQ-8) 865 26.2 472 21.6 213 30.0 180 44.8 <0.001

Due to missing data, percentages may not add up to 100%.

a

mean ± SD (standard deviation): How many weeks pregnant were you during your first prenatal care visit?

b

For continuous variables, P-value was calculated using the one-way ANOVA; for categorical variables, P-value was calculated using the Chi-square test.

Suicidal ideation was endorsed by 16.0% of the cohort, and 26.2% of the cohort fulfilled criteria for depression. Participants with migraine or probable migraine (any migraine) had more than a two-fold increased odds of suicidal ideation (OR=2.17; 95%CI: 1.80–2.61) as compared with non-migraineurs (Table 2). After adjusting for confounders including age, marital status, difficulty paying for the basics, and difficulty paying for medical care, there was still an almost two-fold increase in suicidal ideation (OR=1.99; 95%CI: 1.64–2.41). Further adjustment for depression attenuated the association (OR=1.78; 95%CI: 1.46–2.17), although the association remained statistically significant. Separate analyses for women with migraine or probable migraine diagnosis also showed a consistent increased odds of suicidal ideation (probable migraine: OR=1.74; 95%CI: 1.39–2.19; migraine: OR=1.84; 95%CI: 1.41–2.42) when compared with non-migraineurs after adjusting for all of the above confounders. The magnitude and direction of associations remained similar after stratifying analyses by maternal depression status (Supplemental Table). For instance, after adjusting for confounders among participants with depression, migraineurs had a 1.75–fold increased odds of suicidal ideation as compared to non-migraineurs (OR=1.75;95%CI: 1.28–2.39). Among, participants without depression, migraineurs had a 1.80–fold increased odds of suicidal ideation (OR=1.80;95%CI: 1.40–2.32) as compared with non-migraineurs.

Table 2.

Association of migraine with suicidal ideation during pregnancy (N=3,323)

Migraine No suicidal ideation (N = 2,790)
Suicidal ideation (N = 533)
n % n % Unadjusted OR (95% CI) Adjusted OR (95% CI) a Adjusted OR (95% CI) b
No migraine 1929 69.1 271 50.8 Reference Reference Reference
Any migraine 861 30.9 262 49.2 2.17 (1.80–2.61) 1.99 (1.64–2.41) 1.78 (1.46–2.17)
Types of migraine
 No migraine 1929 69.1 271 50.8 Reference Reference Reference
 Probable migraine 558 20.0 158 29.6 2.02 (1.62–2.51) 1.88 (1.50–2.34) 1.74 (1.39–2.19)
 Migraine 303 10.9 104 19.5 2.44 (1.89–3.16) 2.20 (1.69–2.86) 1.84 (1.41–2.42)

Abbreviations: OR, odds ratio; CI, confidence interval

a

Adjusted for age, marital status, difficulty paying for the very basics, difficulty paying for medical care

b

Adjusted for age, marital status, difficulty paying for the very basics, difficulty paying for medical care, and depression

We next explored the independent and joint effect of migraine and depression on the odds of suicidal ideation (Table 3). In a fully adjusted model, women with depression and no migraine had a 2.44-fold increased odds of suicidal ideation (OR=2.44; 95%CI: 1.85-3.22) as compared with women who had no migraine and no depression (referent group). Those with migraine but no depression had a 1.84-fold increased odds of suicidal ideation (OR=1.84; 95%CI: 1.43–2.36) when compared with the referent group. Pregnant women with comorbid migraine and depression had a 4.14-fold increased odds of suicidal ideation (OR=4.14; 95%CI: 3.17–5.42) compared with those who had neither condition, although the interaction term did not reach statistical significance (p=0.706).

Table 3.

Independent and joint associations of migraine and depression with odds of suicidal ideation

Migraine and Depression Stat us No Suicidal Ideation (N = 2,773)
Suicidal Ideation (N = 524)
n % n % Unadjusted OR (95% CI) Adjusted OR (95% CI) a
(−) Migraine, (−) Depression 1544 55.7 168 32.1 Reference Reference
(−) Migraine, (+) Depression 373 13.5 99 18.9 2.44 (1.86–3.21) 2.44 (1.85–3.22)
(+) Migraine, (−) Depression 593 21.4 127 24.2 1.97 (1.53–2.53) 1.84 (1.43–2.36)
(+) Migraine, (+) Depression 263 9.5 130 24.8 4.54 (3.49–5.91) 4.14 (3.17–5.42)
P value for interaction term 0.783 0.706

Abbreviations: OR, odds ratio; CI, confidence interval

a

Adjusted for age, marital status, difficulty paying for the very basics, and difficulty paying for medical care

Discussion

In this study of pregnant women, those with migraine had increased odds of suicidal ideation even after controlling for depression. Specifically, after adjusting for confounders including depression, migraineurs had almost a 2-fold increased odds (OR=1.78; 95%CI: 1.46–2.17) of suicidal ideation compared with non- migraineurs. Women with both migraine and depression had a 4.14-fold increased odds (OR=4.14; 95%CI: 3.17–5.42) of suicidal ideation compared with those who had neither condition.

Given this is the first study to examine the relation between migraine and suicidal ideation in pregnancy, the results can be tentatively compared with studies that included men and non-pregnant women 3032. In a previous study among 1,007 members of a large Health Maintenance Organization in Michigan, Breslau et al. found a significant association between migraine and thoughts of committing suicide in patients with migraine 31. Similarly, Fuller-Thomson and colleagues in their 2005 Canadian Community Health Survey (a general community-based population), found migraine was associated with increased odds of suicidal ideation in both men and women (men: OR=1.70; 95%CI: 1.55–1.96; women: OR=1.72; 95%CI: 1.59–1.86) although comorbid depression was not taken into account in this analysis 32. In contrast to these studies, a tertiary care hospital-based study of Korean patients (N=238) reported that migraine patients had a 5-fold increased odds of suicidal ideation (OR=5.09; 95%CI: 1.17–22.1) compared with non-migraine patients; however after adjusting for comorbid depression and anxiety, the authors did not find a statistically significant association of suicidal ideation with migraine (OR=1.51; 95% CI: 0.31–7.50) 30.

Our study is the first to find evidence of an association between migraine and suicidal ideation among a cohort of pregnant women. The burden of migraine is particularly high among pregnant women, since migraine headaches are more prevalent among women of childbearing age 6, 33. The prevalence and frequency of headaches, including migraines, can also be altered during pregnancy and is thought to be influenced by hormonal changes across the menstrual cycle and during pregnancy 34. In addition to migraine, additional risk factors make women in low- and middle-income countries particularly vulnerable to suicidal behaviors during pregnancy 35. In our study, the association between migraine and suicidal ideation remained even when we adjusted for multiple confounders including depression.

There are plausible biological mechanisms for the association between migraine and suicidal ideation including shared genetic and neurochemical pathophysiological pathways 36. Genetic and environmental risk factors have been identified for migraine headaches, depression, and suicidal behaviors 37, 38. Studies have linked migraine, depression, and suicidal behaviors to polymorphic alleles of serotonin and dopamine, for example. A recent review of meta-analyses supports the association of serotonin transporter gene-linked polymorphic region (5-HTTLPR) with stress and depression symptoms 39, although this conclusion is controversial 40 . The distribution of polymorphism frequencies in 5-HTTLPR is significantly different among migraine and control patients 41. Another study found 5-HTTLPR does not predispose individuals to develop migraines but may affect the frequency of attacks in migraine patients 42. Studies have also found some evidence of an association between serotonin-related polymorphisms and suicidal behaviors, but the association is far from conclusive 43, 44. Associations of serotonin transporter 5-HTTLPR with affective disorders may be mediated by fluctuations in estradiol and progesterone hormones 45. Polymorphisms in the transcription initiation site of a serotonin transporter (5-HTT) show frequencies of the short allele are increased in migraine with aura patients but not in migraine without aura patients or controls, and this functional polymorphism is hypothesized to be related to migraine 46. There is a significant association between alleles of the serotonin 5-HT2A receptor and both depression and suicide ideation 47. Serotonin transporter function has been shown to be associated to suicidal behavior and depression 48. Neural activity patterns also suggest differences in brain morphology in patients with a history of suicidal behaviors compared to patients without suicidal behavior 49, 50.

There is also evidence suggestive of genetic variations in the dopamine receptor gene associated with migraine, depression, and suicidal behaviors. One study showed increased incidence of migraine, depression, and anxiety disorders in individuals with the dopamine receptor DRD2 NcoI C allele in comparison to an DRD2 NcoI T allele in exon 6 51. Other studies, however, do not support this association 52. In summary, suicidal behaviors have also been associated with variants in genes known to regulate both dopamine and serotonin metabolism 44. Future studies are needed to more fully explore these associations and further elucidate hypothesized mechanisms.

The strengths of our study include a relatively large sample size, the use of well-trained interviewers, and rigorous statistical analytic approaches that included controls for confounding. However, there are some limitations that must be considered. First, because of the cross-sectional study design, we cannot be certain of the temporal relation between migraine and risk of suicidal ideation. Longitudinal studies with more detailed assessment of lifetime and recurrent episodes of suicidal ideation and suicidal behaviors with concomitant assessments of migraine and depression will enhance causal inferences in this area of research. Second, migraine diagnosis was made using a well-established structured questionnaire based on ICHD-III criteria 24. Use of structured interviews is the most feasible method of data collection for large scale epidemiologic studies. Additionally, this study is also subject to recall bias, as subjects are asked about past painful or traumatic experiences, including suicidal thoughts 53. However the effect of this non-differential bias would most likely lead to an attenuation of the true association towards the null value. Lastly, our analysis did not distinguish between migraine with aura and migraine without aura. Migraine subtypes have been shown in previous studies to vary in the strength of their relationship with suicidal ideation, and this may also have attenuated the association reported in our study.

In conclusion, our study suggests that the risk of suicide ideation is increased among pregnant women with migraine. Pending replication, these findings have potential important clinical and public health implications. Specifically our findings suggest it may be important that clinicians treating pregnant women are aware of the comorbidity between migraine, depression, and suicidal behaviors and consider screening pregnant migraineurs for suicidal ideation 32, 54, 55.

Supplementary Material

Acknowledgments

Funding: Eunice Kennedy Shriver Institute of Child Health and Human Development R01-HD-059835

U.S. Department of Health and Human Services: National Institutes of Health

T37-MD-001449

Footnotes

Conflict of Interest: The authors report no relevant conflicts of interest

References

  • 1.Manack AN, Buse DC, Lipton RB. Chronic migraine: epidemiology and disease burden. Current Pain and Headache Reports. 2011;15:70–78. doi: 10.1007/s11916-010-0157-z. [DOI] [PubMed] [Google Scholar]
  • 2.Lanteri-Minet M. Economic burden and costs of chronic migraine. Current Pain and Headache Reports. 2014;18:385. doi: 10.1007/s11916-013-0385-0. [DOI] [PubMed] [Google Scholar]
  • 3.Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurologic Clinics. 2009;27:321–334. doi: 10.1016/j.ncl.2008.11.011. [DOI] [PubMed] [Google Scholar]
  • 4.Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology. 2006;67:246–251. doi: 10.1212/01.wnl.0000225186.76323.69. [DOI] [PubMed] [Google Scholar]
  • 5.Finocchi C, Strada L. Sex-related differences in migraine. Neurological Sciences. 2014;35(Suppl 1):207–213. doi: 10.1007/s10072-014-1772-y. [DOI] [PubMed] [Google Scholar]
  • 6.Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–657. doi: 10.1046/j.1526-4610.2001.041007646.x. [DOI] [PubMed] [Google Scholar]
  • 7.Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache. 2006;46:1327–1333. doi: 10.1111/j.1526-4610.2006.00576.x. [DOI] [PubMed] [Google Scholar]
  • 8.Samaan Z, Farmer A, Craddock N, Jones L, Korszun A, Owen M, McGuffin P. Migraine in recurrent depression: case-control study. British Journal of Psychiatry. 2009;194:350–354. doi: 10.1192/bjp.bp.108.054049. [DOI] [PubMed] [Google Scholar]
  • 9.Breslau N, Lipton R, Stewart W, Schultz L, Welch K. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60:1308–1312. doi: 10.1212/01.wnl.0000058907.41080.54. [DOI] [PubMed] [Google Scholar]
  • 10.World Health Organization. Millennium Development Goal 5 – improving maternal health. 2008. [Google Scholar]
  • 11.Oates M. Perinatal psychiatric disorders: a leading cause of maternal morbidity and mortality. British Medical Bulletin. 2003;67:219–229. doi: 10.1093/bmb/ldg011. [DOI] [PubMed] [Google Scholar]
  • 12.Fuhr DC, Calvert C, Ronsmans C, Chandra PS, Sikander S, De Silva MJ, Patel V. Contribution of suicide and injuries to pregnancy-related mortality in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet Psychiatry. 2014;1:213–225. doi: 10.1016/S2215-0366(14)70282-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Department of Reproductive Health and Research; World Health Organization, editor. Mental health aspects of women's reproductive health: A global review of the literature. 2009. [Google Scholar]
  • 14.Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiologic Reviews. 2008;30:133–154. doi: 10.1093/epirev/mxn002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Han B, Compton WM, Gfroerer J, McKeon R. Prevalence and correlates of past 12-month suicide attempt among adults with past-year suicidal ideation in the United States. Journal of Clinical Psychiatry. 2015;76:295–302. doi: 10.4088/JCP.14m09287. [DOI] [PubMed] [Google Scholar]
  • 16.Oquendo MA, Baca-Garcia E, Mann JJ, Giner J. Issues for DSM-V: suicidal behavior as a separate diagnosis on a separate axis. American Journal of Psychiatry. 2008;165:1383–1384. doi: 10.1176/appi.ajp.2008.08020281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhong QY, Gelaye B, Rondon MB, Sanchez SE, Simon GE, Henderson DC, Barrios YV, Sanchez PM, Williams MA. Using the Patient Health Questionnaire (PHQ-9) and the Edinburgh Postnatal Depression Scale (EPDS) to assess suicidal ideation among pregnant women in Lima, Peru. Archives of Women's Mental Health. 2015;18:783–792. doi: 10.1007/s00737-014-0481-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gavin AR, Tabb KM, Melville JL, Guo Y, Katon W. Prevalence and correlates of suicidal ideation during pregnancy. Archives of Women's Mental Health. 2011;14:239–246. doi: 10.1007/s00737-011-0207-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cripe SM, Sanchez S, Lam N, Sanchez E, Ojeda N, Tacuri S, Segura C, Williams MA. Depressive symptoms and migraine comorbidity among pregnant Peruvian women. Journal of Affective Disorders. 2010;122:149–153. doi: 10.1016/j.jad.2009.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Barrios YV, Sanchez SE, Nicolaidis C, Garcia PJ, Gelaye B, Zhong Q, Williams MA. Childhood abuse and early menarche among Peruvian women. Journal of Adolescent Health. 2015;56:197–202. doi: 10.1016/j.jadohealth.2014.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Barrios YV, Gelaye B, Zhong Q, Nicolaidis C, Rondon MB, Garcia PJ, Sanchez PA, Sanchez SE, Williams MA. Association of childhood physical and sexual abuse with intimate partner violence, poor general health and depressive symptoms among pregnant women. PLoS One. 2015;10:e0116609. doi: 10.1371/journal.pone.0116609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fung J, Gelaye B, Zhong QY, Rondon MB, Sanchez SE, Barrios YV, Hevner K, Qiu C, Williams MA. Association of decreased serum brain-derived neurotrophic factor (BDNF) concentrations in early pregnancy with antepartum depression. BMC Psychiatry. 2015;15:43. doi: 10.1186/s12888-015-0428-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gelaye B, Barrios YV, Zhong QY, Rondon MB, Borba CP, Sanchez SE, Henderson DC, Williams MA. Association of poor subjective sleep quality with suicidal ideation among pregnant Peruvian women. General Hospital Psychiatry. 2015;37:441–447. doi: 10.1016/j.genhosppsych.2015.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia. 2013;33:629–808. doi: 10.1177/0333102413485658. [DOI] [PubMed] [Google Scholar]
  • 25.Kroenke K, Spitzer R, Williams J. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wulsin L, Somoza E, Heck J. The feasibility of using the Spanish PHQ-9 to screen for depression in primary care in Honduras. Primary Care Companion to the Journal of Clinical Psychiatry. 2002;4:191–195. doi: 10.4088/pcc.v04n0504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhong Q, Gelaye B, Fann JR, Sanchez SE, Williams MA. Cross-cultural validity of the Spanish version of PHQ-9 among pregnant Peruvian women: a Rasch item response theory analysis. Journal of Affective Disorders. 2014;158:148–153. doi: 10.1016/j.jad.2014.02.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. General Hospital Psychiatry. 2010;32:345–359. doi: 10.1016/j.genhosppsych.2010.03.006. [DOI] [PubMed] [Google Scholar]
  • 29.Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders. 2009;114:163–173. doi: 10.1016/j.jad.2008.06.026. [DOI] [PubMed] [Google Scholar]
  • 30.Kim SY, Park SP. Suicidal ideation and risk factors in Korean migraine patients. Journal of Clinical Neuroscience. 2014;21:1699–1704. doi: 10.1016/j.jocn.2014.03.016. [DOI] [PubMed] [Google Scholar]
  • 31.Breslau N. Migraine, suicidal ideation, and suicide attempts. Neurology. 1992;42:392–395. doi: 10.1212/wnl.42.2.392. [DOI] [PubMed] [Google Scholar]
  • 32.Fuller-Thomson E, Schrumm M, Brennenstuhl S. Migraine and despair: factors associated with depression and suicidal ideation among Canadian migraineurs in a population-based study. Depression Research and Treatment. 2013 doi: 10.1155/2013/401487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Adeney KL, Flores JL, Perez JC, Sanchez SE, Williams MA. Prevalence and correlates of migraine among women attending a prenatal care clinic in Lima, Peru. Cephalalgia. 2006;26:1089–1096. doi: 10.1111/j.1468-2982.2006.01171.x. [DOI] [PubMed] [Google Scholar]
  • 34.Pearce CF, Hansen WF. Headache and neurological disease in pregnancy. Clinical Obstetrics and Gynecology. 2012;55:810–828. doi: 10.1097/GRF.0b013e31825d7b68. [DOI] [PubMed] [Google Scholar]
  • 35.Gentile S. Suicidal mothers. Journal of Injury and Violence Research. 2011;3:90–97. doi: 10.5249/jivr.v3i2.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hesdorffer DC, Lúđvígsson P, Hauser WA, Ólafsson E, Kjartansson Ó. Co-occurrence of major depression or suicide attempt with migraine with aura and risk for unprovoked seizure. Epilepsy Research. 2007;75:220–223. doi: 10.1016/j.eplepsyres.2007.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Montagna P. Molecular genetics of migraine headaches: a review. Cephalalgia. 2000;20:3–14. doi: 10.1046/j.1468-2982.2000.00003.x. [DOI] [PubMed] [Google Scholar]
  • 38.Mandelli L, Serretti A. Gene environment interaction studies in depression and suicidal behavior: an update. Neuroscience & Biobehavioral Reviews. 2013;37:2375–2397. doi: 10.1016/j.neubiorev.2013.07.011. [DOI] [PubMed] [Google Scholar]
  • 39.Wankerl MWS, Otte C. Current developments and controversies: does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression? Current Opinion in Psychiatry. 2010;23:582–587. doi: 10.1097/YCO.0b013e32833f0e3a. [DOI] [PubMed] [Google Scholar]
  • 40.Jin CXW, Yuan J, Wang G, Cheng Z. Meta-analysis of association between the -1438A/G (rs6311) polymorphism of the serotonin 2A receptor gene and major depressive disorder. Neurological research. 2013;35:7–14. doi: 10.1179/1743132812Y.0000000111. [DOI] [PubMed] [Google Scholar]
  • 41.Borroni B, Brambilla C, Liberini P, Rao R, Archetti S, Gipponi S, Volta GD, Padovani A. Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. Journal of Headache and Pain. 2005;6:182–184. doi: 10.1007/s10194-005-0179-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kotani KST, Shimomura F, Ikawa S, Nanba E. A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache. 2002;42:893–895. doi: 10.1046/j.1526-4610.2002.02209.x. [DOI] [PubMed] [Google Scholar]
  • 43.McGuffin P, Marušic A, Farmer A. What can psychiatric genetics offer suicidology? Crisis. 2001;22:61–65. doi: 10.1027//0227-5910.22.2.61. [DOI] [PubMed] [Google Scholar]
  • 44.Roy A. Genetic and biologic risk factors for suicide in depressive disorders. Psychiatric Quarterly. 1993;64:345–358. doi: 10.1007/BF01064927. [DOI] [PubMed] [Google Scholar]
  • 45.Michopoulos V, Berga SL, Wilson ME. Estradiol and progesterone modify the effects of the serotonin reuptake transporter polymorphism on serotonergic responsivity to citalopram. Experimental and Clinical Psychopharmacology. 2011;19:401–408. doi: 10.1037/a0025008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Marziniak MMR, Schmitt A, Lesch KP, Sommer C. A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology. 2005;64:157–159. doi: 10.1212/01.WNL.0000148597.52312.9E. [DOI] [PubMed] [Google Scholar]
  • 47.Du LBD, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics (Neuropsychiatric Genetics) 2000;96:56–60. doi: 10.1002/(sici)1096-8628(20000207)96:1<56::aid-ajmg12>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  • 48.Purselle DC, Nemeroff CB. Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology. 2003;28:613–619. doi: 10.1038/sj.npp.1300092. [DOI] [PubMed] [Google Scholar]
  • 49.Desmyter S, van Heeringen C, Audenaert K. Structural and functional neuroimaging studies of the suicidal brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011;35:796–808. doi: 10.1016/j.pnpbp.2010.12.026. [DOI] [PubMed] [Google Scholar]
  • 50.Jollant F, Lawrence NS, Giampietro V, Brammer MJ, Fullana MA, Drapier D, Courtet P, Phillips ML. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. American Journal of Psychiatry. 2008;165:740–748. doi: 10.1176/appi.ajp.2008.07081239. [DOI] [PubMed] [Google Scholar]
  • 51.Peroutka SJPS, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Molecular medicine (Cambridge, Mass) 1998;4:14–21. [PMC free article] [PubMed] [Google Scholar]
  • 52.Rebaudengo N, Rainero I, Parziale A, Rosina F, Pavanelli E, Rubino E, Mazza C, Ostacoli L, Furlan PM. Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia. 2004;24:503–507. doi: 10.1111/j.1468-2982.2004.00689.x. [DOI] [PubMed] [Google Scholar]
  • 53.Tietjen GE, Peterlin BL. Childhood abuse and migraine: epidemiology, sex differences, and potential mechanisms. Headache. 2011;51:869–879. doi: 10.1111/j.1526-4610.2011.01906.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Fuller-Thomson E, Hamelin GP, Granger SJ. Suicidal ideation in a population-based sample of adolescents: implications for family medicine practice. ISRN Family Medicine. 2013;2013:282378. doi: 10.5402/2013/282378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Park SP, Seo JG, Lee WK. Osmophobia and allodynia are critical factors for suicidality in patients with migraine. Journal of Headache and Pain. 2015;16:529. doi: 10.1186/s10194-015-0529-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

RESOURCES